New Clinical Trials for High Cholesterol

High cholesterol has dangerous affects on arteriesHigh cholesterol is an important condition to diagnose, manage and treat, both on its own and as an indicator of other problems. If you have high cholesterol and have tried to treat it unsuccessfully with diet and exercise, or even with medication, we would like to talk to you. There is much more to learn and ongoing high cholesterol clinical studies are needed.

(For more information, please see: High Cholesterol Symptoms, High Cholesterol Drugs & Medication, and High Cholesterol Causes)

There are ongoing high cholesterol clinical trials that you can participate in if you qualify. Please review the list and contact us if you are interested in participating. As always there is no cost to you to participate in clinical trials.

What is High Cholesterol?

High cholesterol, also known as hypercholesterolemia, is a condition where there are high levels of cholesterol in the blood. High cholesterol can have many causes, but the main one is heart disease. It is closely related to hyperlipidemia that occurs when there are a high number of lipids found in the blood. Diet, genetics, diabetes, and an under-active thyroid are other potential causes for high cholesterol. The U.S. Preventative Services Task Force recommends screening for high cholesterol as an early indicator of heart disease. Cholesterol is made up of different types of fat – LDL, HDL and VLDL. It is important to measure each when determining harmful levels of cholesterol.

High Cholesterol Treatments

High cholesterol treatments include lifestyle changes. In obese people with high cholesterol that has been caused by their diet, the condition can sometimes be improved when they improve their diet. Quitting smoking and reducing the intake of alcohol can also be helpful. If lifestyle changes don’t work, then drugs may be prescribed. The American College of Physicians has set some guidelines for the treatment of high cholesterol. Treating high cholesterol may involve the use of statins and lipid lowering therapies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,593 High Cholesterol
clinical trials

Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
DeLand, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
High Cholesterol Clinical Trial
Status: Upcoming
Updated: 1/1/1970
mi
from
DeLand, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Status: Enrolling, Phase III
Updated: 12/23/2015
mi
from
DeLand, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Novel Therapies for Metabolic Complications of Lipodystrophies
Status: Enrolling, Phase II, III
Updated: 6/19/2013
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
Status: Enrolling, Phase I
Updated: 9/5/2014
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
Status: Enrolling, Phase I, II
Updated: 3/7/2011
mi
from
Columbia, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Status: Enrolling
Updated: 3/15/2013
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Eugene, OR
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Evansville, IN
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Lansdale, PA
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Richmond, VA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Stanford, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
mi
from
Eugene, OR
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Acute Microvascular Changes With LDL Apheresis
Status: Enrolling
Updated: 10/23/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Auburn, ME
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Richmond, VA
Click here to add this to my saved trials
Homozygous Familial Hypercholesterolemia Clinical Trial
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Status: Enrolling
Updated: 2/8/2016
mi
from
New York, NY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Bristol, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Cary, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Hialeah, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Savannah, GA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Lipoproteins
Status: Enrolling
Updated: 3/11/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
mi
from
Rochester, MN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Avon, IN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Columbia, SC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Kenosha, WI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Norwalk, CT
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/23/2016
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
Status: Enrolling
Updated: 3/28/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling, Phase II, III
Updated: 3/29/2016
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Hialeah, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Albany, NY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Athens, AL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Carmichael, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Honolulu, HI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Huntsville, AL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Liverpool, NY
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Medford, OR
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Meridian, ID
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Murray, UT
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Northridge, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Oviedo, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Renton, WA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Tomball, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women
Status: Enrolling
Updated: 3/20/2012
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Status: Enrolling
Updated: 6/23/2005
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Endothelial Hyperpolarization in Humans
Status: Enrolling, Phase II
Updated: 8/28/2014
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 4/15/2013
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pharmacology / Toxicology Clinical Trial
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Status: Enrolling
Updated: 11/24/2015
mi
from
Berkeley, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases, Pharmacology / Toxicology Clinical Trial
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Status: Enrolling
Updated: 3/3/2015
mi
from
New Haven, CT
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling, Phase II
Updated: 1/13/2014
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling, Phase II
Updated: 10/5/2015
mi
from
Cinncinati, OH
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
mi
from
Tustin, CA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 16